相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Impact of Disease Comorbidities in Alzheimer's Disease
Jose A. Santiago et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease
Michele Rossi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses
Agnieszka Brzezinska et al.
CURRENT ALZHEIMER RESEARCH (2020)
The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice
Hao Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents
Yixiang Xu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity
Baoli Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial
Davangere P. Devanand et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
Qi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care
Stephen J. Ralph et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo
Shuaishuai Ni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study
Jorge Browne et al.
BMJ OPEN (2017)
The role of 5-HT receptors in depression
Christine N. Yohn et al.
MOLECULAR BRAIN (2017)
Novel Vilazodone Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation
Xiaokang Li et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases
Cornelis J. Van der Schyf
DRUG DEVELOPMENT RESEARCH (2016)
Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders
Priya Bawa et al.
DRUG DISCOVERY TODAY (2016)
The 5-HT1A receptor in Major Depressive Disorder
Joshua Kaufman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
Qing-Fei Zhao et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents
Xiaokang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Alzheimer's Disease associated with Psychiatric Comorbidities
Michelle L. Garcez et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2015)
The Prevalence of Depression in Alzheimer's Disease: A Systematic Review and Meta-Analysis
Song Chi et al.
CURRENT ALZHEIMER RESEARCH (2015)
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride
Christophe Rochais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Depression associated with dementia
H. Gutzmann et al.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2015)
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia Number Needed to Harm
Donovan T. Maust et al.
JAMA PSYCHIATRY (2015)
Behavioral and Psychological Symptoms in Alzheimer's Disease
Xiao-Ling Li et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Epidemiological Modelling of Major Depressive Disorder: Application for the Global Burden of Disease Study 2010
Alize J. Ferrari et al.
PLOS ONE (2013)
Behavioral and Psychological Symptoms of Dementia
J. Cerejeira et al.
Frontiers in Neurology (2012)
Depression and risk of developing dementia
Amy L. Byers et al.
NATURE REVIEWS NEUROLOGY (2011)
5-HT1A receptor-regulated signal transduction pathways in brain
Abigail M. Polter et al.
CELLULAR SIGNALLING (2010)
Development of an Efficient Therapeutic Agent for Alzheimer's Disease: Design and Synthesis of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter
Narihiro Toda et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
Inge Klinkenberg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
Lee A. Dawson et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Arif Khan
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
5-HT1A receptor function in major depressive disorder
Jonathan Savitz et al.
PROGRESS IN NEUROBIOLOGY (2009)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Targeting acetylcholinesterase to treat neurodegeneration
Ulrike Holzgrabe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Novel acetylcholinesterase inhibitor as increasing agent on rhythmic bladder contractions:: SAR of 8-{3-[1-(3-fluorobenzyl)piperidin-4-yl]propanoyl}-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one (TAK-802) and related compounds
Y Ishichi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Indolebutylamines as selective 5-HT1A agonists
T Heinrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Synthesis and structure-activity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors
T Heinrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
M Vaswani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Role of serotonin in memory impairment
HC Buhot et al.
ANNALS OF MEDICINE (2000)
分享论文
